PBM Capital
Private equityCharlottesville · Seed–Late Stage · 6 people tracked
Investment thesis
PBM Capital invests in pharmaceutical and life sciences companies with game-changing technologies capable of improving and saving lives. The firm seeks entrepreneurs whose vision aligns with its thesis and whom it trusts to execute at scale. PBM Capital provides not only capital but also operational support and expertise derived from its founder's track record building and scaling healthcare companies. The firm focuses on companies with significant growth potential, evidenced by its portfolio's three IPO exits since 2016.
Source: firm website, verified Jul 21, 2026.
Team · 6 people
from the firm's websiteFounder of PBM Capital who previously built PBM Products from inception with minimal initial capital into the world's leading private label infant formula supplier serving over 50,000 retail stores, which was sold to Perrigo for over $800 million.
Investments · 3 tracked
founders shown can be your intro pathPublicly listed pharmaceutical company
Publicly listed pharmaceutical company
Board seats · per SEC filings
what is this? ⓘ$30M raise · filed Jun 2021 · via Jayson Rieger, Paul B. Manning
Inferred from directors named on each company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- What stage does PBM Capital invest at?
- PBM Capital invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does PBM Capital focus on?
- PBM Capital focuses on Biotech, Healthtech, Medical Devices.
- Where is PBM Capital located?
- PBM Capital is headquartered in Charlottesville, US.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
USVP is a venture capital firm with over 40 years of history across four generations of technology investing. The firm has deployed $4.7B across 542 companies, generating 97 IPOs, and combines 150 years of combined operating experience with deep expertise in enterprise software, security, consumer technology, and healthcare.
A venture capital firm that supports founders developing transformative solutions across interconnected systems, with a particular focus on leveraging artificial intelligence and related technologies to advance health and human flourishing.